SCHEMBL17853566

SCHEMBL17853566

c1ccc(-c2cccc(-c3nc(-c4ccc(-c5cccnc5)cc4)cc(-c4ccc(-n5c6ccccc6c6ccccc65)cc4)n3)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 1/20 0.47
▸ CYP19A1 P11511 2/20 0.45
▸ CYP17A1 P05093 1/20 0.42
▸ CYP11B1 P15538 1/20 0.42
▸ CYP11B2 P19099 1/20 0.42
▸ PGR P06401 1/20 0.39
▸ KMO O15229 1/20 0.39
▸ MAPT P10636 4/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ ATM Q13315 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ G6PD P11413 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ HPGD P15428 2/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ MKNK1 Q9BUB5 1/20 0.38
▸ MKNK2 Q9HBH9 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ KDR P35968 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17853490 0.95 DHODH (0.45) DHODHCYP19A1CYP17A1CYP11B1CYP11B2
SCHEMBL19397646 0.94 DHODH (0.50) DHODHCYP19A1CYP17A1CYP11B1CYP11B2
SCHEMBL17853486 0.94 DHODH (0.50) DHODHCYP19A1CYP17A1CYP11B1CYP11B2
SCHEMBL17853693 0.94 DHODH (0.50) DHODHCYP19A1CYP17A1CYP11B1CYP11B2
SCHEMBL17853564 0.94 DHODH (0.50) DHODHCYP19A1CYP17A1CYP11B1CYP11B2
SCHEMBL17853561 0.94 DHODH (0.50) DHODHCYP19A1CYP17A1CYP11B1CYP11B2
SCHEMBL17853546 0.94 DHODH (0.50) DHODHCYP19A1CYP17A1CYP11B1CYP11B2
SCHEMBL24252239 0.93 DHODH (0.44) DHODHCYP19A1CYP17A1CYP11B1CYP11B2
SCHEMBL19397640 0.93 CYP19A1 (0.49) DHODHCYP19A1CYP11B1MAPTKDM4E
SCHEMBL19397486 0.91 DHODH (0.44) DHODHCYP19A1CYP17A1CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160181564-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 — — US disclosed
US-20160181564-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160181564-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE LEF1, PIEZO1, SLC39A11 DHODH 3921/4885CYP19A1 482/4885CYP17A1 1655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback